Sanofi’s neurology pipeline has had a hole blown in it after a phase 3 trial of riliprubart in rare disease CIDP was stopped for futility.

May saw a drug ad spending slump across the majority of the top ten drug ad spenders with AbbVie’s Skyrizi and RInvoq, Johnson & Johnson’s

Patients with Lynch syndrome could have a potential treatment on the horizon, as a Moderna mRNA vaccine starts trials at Oxford University.

EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.

A survey has shown that UK doctors think AI can help them save time and expand their capacity to care for patients, but training is